Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_assertion type Assertion NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_head.
- NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_assertion wasGeneratedBy ECO_0000203 NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_provenance.
- NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_assertion wasDerivedFrom befree-2016 NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_provenance.
- NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_assertion SIO_000772 24468836 NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_provenance.
- NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_assertion evidence source_evidence_literature NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_provenance.
- NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_provenance.